Vitamin D-responsive SGPP2 variants associated with lung cell expression and lung function

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Reardon, Brian J ^a   Hansen, Joyanna G ^a   Crystal, Ronald G ^b   Houston, Denise K ^c   Kritchevsky, Stephen B ^c   Harris, Tamara ^d   Lohman, Kurt ^c   Liu, Yongmei ^c   O'Connor, George T ^e,f   Wilk, Jemma B ^f,g   Mezey, Jason ^b,h   Gao, Chuan ^h   Cassano, Patricia A ^a,b  

^a Cornell University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h Program on Infrastructure Policy   (United States)

Author keywords

Airflow obstruction; FEV1; FEV1 FVC; SGPP2; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; DEATH ASSOCIATED PROTEIN KINASE; KRUPPEL LIKE FACTOR 4; PHOSPHATASE; PROSTAGLANDIN E RECEPTOR 2; SGPP2 PROTEIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGED; AGING; AIRWAY OBSTRUCTION; ARTICLE; BODY COMPOSITION; CHROMOSOME; COHORT ANALYSIS; EUROPEAN AMERICAN; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; QUANTITATIVE TRAIT LOCUS; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT;

AFRICAN AMERICANS; AGED; AGING; BODY COMPOSITION; COHORT STUDIES; EPITHELIAL CELLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RESPIRATORY FUNCTION TESTS; VITAMIN D;

EID: 84888103206     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-122     Document Type: Article

References (34)

1. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005, 19(11):2685-2695. 10.1210/me.2005-0106, 16002434.
2. Ross AC, Institute of Medicine (U. S.). Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Dietary reference intakes for calcium and vitamin D 2011, Washington, DC: National Academies Press, Institute of Medicine (U. S.). Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.
3. Looker AC, Lacher DA, et al. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011, 59:1-7.
4. Minino AM. Death in the United States, 2009. NCHS Data Brief 2011, (64):1-8.
5. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182(5):693-718. 10.1164/rccm.200811-1757ST, 20802169.
6. Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr 2011, 2:244-253. 10.3945/an.111.000398, 3090167, 22332056.
7. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128(6):3792-3798. 10.1378/chest.128.6.3792, 16354847.
8. Shaheen SO, Jameson KA, Robinson SM, Boucher BJ, Syddall HE, Aihie Sayer A, Cooper C, Holloway JW, Dennison EM. Relationship of vitamin D status to adult lung function and COPD. Thorax 2011, 66(8):692-698. 10.1136/thx.2010.155234, 21653927.
9. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, Decallonne B, Bouillon R, Decramer M, Janssens W. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Int Med 2012, 156(2):105-114. 10.7326/0003-4819-156-2-201201170-00004, 22250141.
10. Kunisaki KM, Niewoehner DE, Connett JE. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: A prospective cohort study. Am J Respir Crit Care Med 2012, 185(3):286-290. 10.1164/rccm.201109-1644OC, 3297108, 22077070.
11. Wittke A, Chang A, Froicu M, Harandi OF, Weaver V, August A, Paulson RF, Cantorna MT. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch Biochem Biophys 2007, 460(2):306-313. 10.1016/j.abb.2006.12.011, 1933487, 17224129.
12. Bosse Y, Maghni K, Hudson TJ. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol Genomics 2007, 29(2):161-168.
13. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008, 181(10):7090-7099. 2596683, 18981129.
14. Harvey BG, Heguy A, Leopold PL, Carolan BJ, Ferris B, Crystal RG. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med (Berl) 2007, 85(1):39-53.
15. Gao C, Tignor N, Salit J, Strulovici-Barel Y, Hackett N, Crystal RG, Mezey JG. HEFT: eQTL analysis of many thousands of expressed genes while simultaneously controlling for hidden factors. Bioinformatics 2013, in press.
16. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010, 26(18):2336-2337. 10.1093/bioinformatics/btq419, 2935401, 20634204.
17. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010, 42(1):45-52. 10.1038/ng.500, 2832852, 20010835.
18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805, 16055882.
19. Waterer GW, Wan JY, Kritchevsky SB, Wunderink RG, Satterfield S, Bauer DC, Newman AB, Taaffe DR, Jensen RL, Crapo RO. Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 2001, 49(8):1032-1038. 10.1046/j.1532-5415.2001.49205.x, 11555063.
20. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011, 105(6):907-915. 10.1016/j.rmed.2011.01.008, 21295958.
21. Artigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011, 43:1082-1090. 10.1038/ng.941, 3267376, 21946350.
22. Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 2011, 12(9):628-640. 10.1038/nrg3046, 21850043.
23. Storey JD. A direct approach to false discovery rates. J R Statist Soc B 2002, 64:479-498.
24. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, Taylor J, Burnett E, Gut I, Farrall M, et al. A genome-wide association study of global gene expression. Nat Genet 2007, 39(10):1202-1207. 10.1038/ng2109, 17873877.
25. Yang Y, Uhlig S. The role of sphingolipids in respiratory disease. Ther Adv Respir Dis 2011, 5(5):325-344. 10.1177/1753465811406772, 21900155.
26. Chi H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci 2011, 32(1):16-24. 10.1016/j.tips.2010.11.002, 3017656, 21159389.
27. Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, et al. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 2007, 19(4):748-760. 10.1016/j.cellsig.2006.09.004, 17113265.
28. Houle F, Poirier A, Dumaresq J, Huot J. DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress. J Cell Sci 2007, 120(Pt 20):3666-3677.
29. Mukhopadhyay R, Ray PS, Arif A, Brady AK, Kinter M, Fox PL. DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol Cell 2008, 32(3):371-382. 10.1016/j.molcel.2008.09.019, 2644327, 18995835.
30. Hao K, Niu T, Xu X, Fang Z. Single-nucleotide polymorphisms of the KCNS3 gene are significantly associated with airway hyperresponsiveness. Hum Genet 2005, 116(5):378-383. 10.1007/s00439-005-1256-5, 15714333.
31. Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006, 61(8):671-677. 10.1136/thx.2005.052241, 2104688, 16670173.
32. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, Robbins P, Hirsch R. Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol 2006, 177(7):4758-4762.
33. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000, 118(3):656-664. 10.1378/chest.118.3.656, 10988186.
34. Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor - an update on mechanisms. Rev Endocr Metab Disord 2012, 13(1):45-55. 10.1007/s11154-011-9198-9, 21870057.